KIF9 and inflammatory bowel disease: Moreover, differences in expression levels have been also found for various novel lncRNAs (e.g., KIF9-AS1, LINC01272, and DIO3OS) in tissue and plasma samples of patients with IBD, rendering them as potential biomarkers of therapeutic or diagnostic value for IBD [180].